NCT07766200

Brief Summary

This observational cross-sectional study aims to determine pain phenotypes in individuals with chronic low back pain (CLBP). Participants will be classified according to a mechanism-based clinical pain phenotyping algorithm as having nociceptive, neuropathic, nociplastic, or mixed pain. Clinical history, quantitative sensory assessment, pain characteristics and distribution, central sensitization-related symptoms, disability, health-related quality of life, and pain catastrophizing will be assessed. In addition, the intra-rater and inter-rater reliability of the pain phenotyping algorithm will be investigated, and the clinical characteristics of different pain phenotypes will be compared.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
4mo left

Started Jan 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress81%
Jan 2025Dec 2026

Study Start

First participant enrolled

January 2, 2025

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

August 11, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 14, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

August 14, 2026

Status Verified

August 1, 2026

Enrollment Period

1.8 years

First QC Date

August 11, 2026

Last Update Submit

August 11, 2026

Conditions

Keywords

pain phenotypepain sciencechronic painnociplastic pain

Outcome Measures

Primary Outcomes (6)

  • Quantitative sensory test: static tactile mechanical threshold

    Von Frey Monofilaments (2 gr- 26 gr) will be used assessment for the static tactile mechanical detection threshold.

    10 minutes

  • Quantitative sensory test: hot-cold pain threshold

    Coins will be used for the hot-cold pain threshold. The cold sensing test will be done with a coin held at room temperature. The hot sensing test will be done in the form of a coin placed in the pocket and applied to the participant after waiting for 30 minutes.

    5 minutes

  • Quantitative sensory test: static mechanical allodynia

    A digital algometer device (JTech) will be used for static mechanical allodynia (pressure pain threshold). In the device, the pain sensation will be tested by applying 4 kg of pressure to the participant.

    5 minutes

  • Quantitative sensory test: dynamic mechanical allodynia

    A soft brush will be used for dynamic mechanical allodynia. The brush will be gently moved over the skin at a speed of 3-5 cm per second in a fixed direction over the patients primary painful area.

    5 minutes

  • Quantitative sensory test: vibration sense

    128 Hz tuning fork will be used in vibration assessment. The device will be applied over the bony prominences in the painful area of the patient.

    5 minutes

  • Margolis Pain Diagram

    The Margolis Pain Diagram, consists of a dorsal and a ventral drawing body, is used to assess the location and distribution of the pain \[20\]. Participants will ask to point out the place where they experience pain during the preceding 4 weeks for at least 24 hours.

    1 minute

Secondary Outcomes (5)

  • Central Sensitization Inventory (CSI)

    5 minutes

  • Oswestry Disability Index (ODI)

    5 minutes

  • Health-Related Quality of Life - SF-12

    5 minutes

  • Pain Catastrophizing Scale (PCS)

    5 minutes

  • Numeric pain rating scale

    1 minute

Interventions

A current clinical algorithm will be used to determine the predominant type of pain in individuals with clip. The classification to diagnose nociceptive, neuropathic and nociplastic pain will based on a recent method developed by Nijs et al. This method consists of seven steps in total. These steps question the following, respectively: duration of pain, pain distribution, presence of nociceptive pain, presence of neuropathic pain, phenomenon of hypersensitivity, presence of hypersensitization and presence of specific comorbidity. Besides, inter-rater and intra-rater reliability of pain classification algorithm will be determined by two independent researchers.

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants meeting the inclusion criteria will be taken for this cross-sectional study. Individuals with cLBP who apply to Kutahya Health Sciences University Hospital Physiotherapy Department will be screened for eligibility by their clinic physicians and will then be asked to participate in this study.

You may qualify if:

  • Low back pain persisting for at least 3 months or present for at least 3 months during the previous 6 months, defined as pain located between the posterior lower costal margins and the inferior gluteal folds
  • Pain intensity ≥2 on the Numeric Rating Scale
  • Willingness to participate in the study

You may not qualify if:

  • Inability to read and write Turkish
  • History of lumbar surgery
  • Presence of a systemic condition affecting sensory function
  • History of spinal surgery within the previous 6 months or suspected spinal fracture
  • Inability to complete the study assessments

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kutahya Health Sciences University Physical Medicine and Rehabilitation Department

Kütahya, Türkiye, 43100, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Chronic PainNociplastic Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Ismail Saracoglu, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

August 11, 2026

First Posted

August 14, 2026

Study Start

January 2, 2025

Primary Completion (Estimated)

October 30, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

August 14, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Locations